Hamptons Homebuildi...
Health Care: Drugs
Intercept Pharmaceuticals Inc (ICPT: NASDAQ)
$34.36 0.19 | 0.56%
05/24/13 - 04:00 PM ET
20.57K / 34.60K
Vol / Avg. Vol:34.33 / 34.17
Open / Prev. Close:34.24 - 34.51
Today's Range:17.96 - 42.67
52 Wk Range:-3.91%
Performance YTD:TheStreet Rating:
Portfolios with ICPT
- Portfolio NameUser Type
Latest ICPT Headlines from TheStreet
- Intercept Pharmaceuticals Announces Additional Results Of Global Primary Biliary Cirrhosis Study Group Analysis Presented At EASL 04.30.13 | 08:04 am
- Intercept Pharmaceuticals To Present At Upcoming Healthcare Conferences 04.25.13 | 04:04 pm
- Intercept Pharmaceuticals Announces Upcoming EASL Presentation 04.08.13 | 08:04 am
- Intercept Pharmaceuticals Announces 2012 Financial Results And Provides Business Update 03.18.13 | 04:03 pm
- Intercept Pharmaceuticals To Host 2012 Fourth Quarter And Full Year Financial Results Conference Call On March 18 03.12.13 | 06:03 am
- Intercept Pharmaceuticals Appoints Daniel Regan As Chief Commercial Officer 03.04.13 | 08:03 am
- Intercept Pharmaceuticals To Present At The Cowen And Company 33rd Annual Healthcare Conference 02.25.13 | 05:02 pm
- Intercept Pharmaceuticals To Present At Leerink Swann 2013 Global Healthcare Conference 02.07.13 | 05:02 pm
- Cramer's 'Mad Money' Recap: Getting Good News From the Headlines 01.28.13 | 07:01 pm
- Intercept Pharmaceuticals Announces Initiation Of Phase 2 NASH Trial Of OCA In Japan 01.07.13 | 05:01 pm
Press Releases for ICPT
Partner Headlines for ICPT
- UPDATE: BMO Capital Markets Initiates Intercept Pharmaceuticals at Outperform on Outlook - Benzinga 11.05.12 | 12:11 pm
